Research Analysts’ Recent Ratings Updates for CONMED (CNMD)

A number of firms have modified their ratings and price targets on shares of CONMED (NYSE: CNMD) recently:

• 11/4/2026 – CONMED was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 10/29/2026 – CONMED had its price target raised by JPMorgan Chase & Co. from $45.00 to $50.00. They now have a “neutral” rating on the stock.
• 10/29/2026 – CONMED had its price target raised by Wells Fargo & Company from $46.00 to $49.00. They now have an “equal weight” rating on the stock.
• 10/21/2026 – CONMED was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 10/6/2026 – CONMED was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
• 9/17/2026 – CONMED was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.

CONMED Price Performance

CONMED stock traded down $0.70 during midday trading on Tuesday, reaching $51.23. The company’s stock had a trading volume of 225,157 shares, compared to its average volume of 503,007. The company has a current ratio of 1.49, a quick ratio of 0.70 and a debt-to-equity ratio of 0.60. The stock has a market cap of $1.53 billion, a PE ratio of 21.17, a price-to-earnings-growth ratio of 2.49 and a beta of 0.90. CONMED Corporation has a 52 week low of $31.44 and a 52 week high of $54.80. The business has a 50-day moving average price of $47.04 and a 200-day moving average price of $41.72.

CONMED (NYSE:CNMD) last posted its earnings results on Wednesday, October 28th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $335.56 million during the quarter, compared to analysts’ expectations of $336.28 million. CONMED had a net margin of 5.36% and a return on equity of 13.93%. The business’s revenue for the quarter was down .7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.08 earnings per share. On average, sell-side analysts predict that CONMED Corporation will post 4.58 EPS for the current year.

CONMED Corporation is a medical technology company that develops and markets devices and equipment for orthopedic and general surgery. Its products support minimally invasive procedures and include arthroscopy systems, powered surgical instruments, electrosurgical equipment, and endoscopic technologies. The company was founded in 1970 and serves hospitals, surgery centers, and other healthcare providers. Its products are sold in the United States and internationally.